Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer.

Ferran Guedea; Ferran Aguilo; Alfredo Polo; Stephen Langley; Robert Laing; Alastair Henderson; Sirpa Aaltomaa; Vesa Kataja; Juni Palmgren; Franch Bladou

doi:10.1016/j.radonc.2006.06.004

Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer.

Identifier:nobleid.org/w1/20260515/667ADBB6

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/667ADBB6.svg?ark=w1%2F20260515%2F667ADBB6)](https://nobleid.org/work/w1/20260515/667ADBB6)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer.

Identifier:nobleid.org/w1/20260515/667ADBB6

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/667ADBB6.svg?ark=w1%2F20260515%2F667ADBB6)](https://nobleid.org/work/w1/20260515/667ADBB6)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work